CA1030449A - Vaccin contre l'influenza contenant un virus recombinant a antigenicite hybride et mode d'utilisation dudit vaccin - Google Patents

Vaccin contre l'influenza contenant un virus recombinant a antigenicite hybride et mode d'utilisation dudit vaccin

Info

Publication number
CA1030449A
CA1030449A CA180,962A CA180962A CA1030449A CA 1030449 A CA1030449 A CA 1030449A CA 180962 A CA180962 A CA 180962A CA 1030449 A CA1030449 A CA 1030449A
Authority
CA
Canada
Prior art keywords
antigenically
hybridized
recombinant
virus
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA180,962A
Other languages
English (en)
Other versions
CA180962S (en
Inventor
Edwin D. Kilbourne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai School of Medicine filed Critical Mount Sinai School of Medicine
Application granted granted Critical
Publication of CA1030449A publication Critical patent/CA1030449A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA180,962A 1972-09-25 1973-09-13 Vaccin contre l'influenza contenant un virus recombinant a antigenicite hybride et mode d'utilisation dudit vaccin Expired CA1030449A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29179772A 1972-09-25 1972-09-25

Publications (1)

Publication Number Publication Date
CA1030449A true CA1030449A (fr) 1978-05-02

Family

ID=23121873

Family Applications (1)

Application Number Title Priority Date Filing Date
CA180,962A Expired CA1030449A (fr) 1972-09-25 1973-09-13 Vaccin contre l'influenza contenant un virus recombinant a antigenicite hybride et mode d'utilisation dudit vaccin

Country Status (3)

Country Link
CA (1) CA1030449A (fr)
GB (1) GB1413401A (fr)
PH (1) PH12704A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300467D0 (en) * 1983-01-08 1983-02-09 Wellcome Found Equine influenza
FI20051255A0 (fi) * 2005-12-05 2005-12-05 Pekka Untamo Heino Seuraavaa influenssa A-pandemiaa vastaan soveltuva rokote

Also Published As

Publication number Publication date
AU6067573A (en) 1975-03-27
GB1413401A (en) 1975-11-12
PH12704A (en) 1979-07-20

Similar Documents

Publication Publication Date Title
NL7510535A (nl) Werkwijze ter bereiding van nieuwe arylpiperi- dinen, alsmede werkwijze ter bereiding van farmaceutische preparaten.
AU477107B2 (en) New alkoxyalkyl-1. 4-dihydropyridines their preparation, and their medicinal use
ZA745571B (en) Live influenza virus vaccines and preparation thereof
AU5983473A (en) New 2-amino-1, 4-dihydropyridines, their production, and their medicinal use
CA983851A (en) Killed vaccine for infectious porcine atrophic rhinitis and process for preparing the same
ZA747602B (en) Influenza vaccines
AU7730575A (en) Influenza vaccine
CA1030449A (fr) Vaccin contre l'influenza contenant un virus recombinant a antigenicite hybride et mode d'utilisation dudit vaccin
AU502636B2 (en) Vaccine from attenuated virus
AU5949773A (en) Tge virus vaccine
AU492612B2 (en) Influenza vaccine containing a recombinant antigenically hybridized virus and method of using thesame
SE7509123L (sv) 3-metylpyrazol-5-karboxylat, sett att framstella desamma och lekemedelpreparat innehallande desamma.
AU473292B2 (en) 6-methylprednisolone derivatives, process for the preparation thereof and pharmaceutical compositions containing same
ZA753811B (en) N-sulphenylated arylcarbamates, processes for their preparation, and their use as insecticides.
AU494738B2 (en) Virus subunit vaccine
AU7444974A (en) Virus subunit vaccine
NL7600443A (nl) Influenza vaccin, dat gezuiverd neuraminidase-an- tigeen bevat en de bereiding daarvan.
CA917073A (en) Vaccine against viral hepatitis and process
AU7946675A (en) Vaccine from attenuated virus
CA916592A (en) Viral vaccines
CA1014965A (en) .alpha.-PYRONE DERIVATIVES, PREPARATIONS AND USES THEREOF
AU2611577A (en) Live influenza virus vaccine
CA962943A (en) Insect virus compositions and process
AU497239B2 (en) Parainfluenza virus vaccine
IL46446A0 (en) Live influenza type b virus vaccines and preparation thereof